Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112125856A reveals a safe palladium-catalyzed route to 2-trifluoromethyl quinazolinones using solid CO surrogates, offering significant cost and safety advantages for pharmaceutical manufacturing.
Patent CN112480015B details a novel one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction in API manufacturing.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for quinazolinones. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering significant supply chain advantages for API manufacturing.
Patent CN112480015B reveals a novel one-pot method for synthesizing 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN112480015B details a novel one-pot synthesis for 2-trifluoromethyl quinazolinones using nitro compounds, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chain solutions.
Patent CN106957273A reveals copper-catalyzed route for quinazolinones. Offers mild conditions and high yields for scalable pharmaceutical intermediates manufacturing supply.
Novel FeCl3-catalyzed cyclization method offers high yields and cost-effective production for pharmaceutical intermediates.
Novel Pd-catalyzed one-pot method offers cost-effective route for high-purity quinazolinone APIs with broad substrate tolerance.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route to 2-trifluoromethyl quinazolinones, offering reliable supply chain solutions for API manufacturing.
Novel FeCl3-catalyzed route for quinazolinones offers high yields and cost efficiency for pharmaceutical intermediate manufacturing and supply chain stability.
Novel Pd-catalyzed carbonylation method for quinazolinones offers high yield and scalability for pharmaceutical intermediates.
Patent CN112480015B reveals a one-pot method for 2-trifluoromethyl quinazolinones, offering high yields and scalable pharma intermediate production.
Patent CN111675662B reveals a cost-effective iron-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply chains.
Novel Pd-catalyzed carbonylation method offers cost-effective route for high-purity quinazolinone APIs with broad substrate tolerance.
Patent CN111675662B reveals a cost-effective FeCl3-catalyzed route for 2-trifluoromethyl quinazolinones, offering reliable pharmaceutical intermediate supply and simplified purification.
Patent CN112480015B reveals an efficient Pd-catalyzed route for high-purity quinazolinone intermediates, offering significant cost and supply chain advantages.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for quinazolinone derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112480015B details a novel Pd-catalyzed one-pot synthesis for 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain advantages for pharmaceutical intermediates.